Global overview of injecting drug use and HIV infection among injecting drug users
Global overview of injecting drug use and HIV infection among injecting drug users
复制标题
DOI：
10.1097/00002030-200411190-00010
复制
发表时间：
2004-11-19
期刊：
影响因子：
3.8
通讯作者：
Rhodes, T
中科院分区：
文献类型：
--
作者：
Aceijas, C;Stimson, GV;Rhodes, T
目的：提供注射吸毒流行率和注射吸毒者中艾滋病毒流行率的全球估计数，特别是提供发展中国家和转型期国家的估计数。的信息的证据的强度进行了评估的基础上的来源和类型的study.Results：估计IDU流行率为130个国家。全世界注射吸毒者人数估计约为1，320万。1000多万人（78%）生活在发展中国家和转型期国家（东欧和中亚310万人、南亚和东南亚330万人、东亚和太平洋230万人）。有78个国家的艾滋病毒流行率估计数。据报告，在25个国家和地区的至少一个地点，注射吸毒者中的艾滋病毒流行率超过20%：白俄罗斯、爱沙尼亚、哈萨克斯坦、俄罗斯、乌克兰、意大利、荷兰、葡萄牙、塞尔维亚和黑山、西班牙、利比亚、印度、印度尼西亚、马来西亚、缅甸、尼泊尔、泰国、越南、中国、阿根廷、巴西、乌拉圭、波多黎各、美国和加拿大。这些调查结果更新了以前对有注射吸毒者和感染艾滋病毒的注射吸毒者的国家数目的评估，以及以前对注射吸毒流行率的全球定量估计。然而，信息仍然存在差距，证据的力度往往很弱。(C)2004年利平科特威廉姆斯威尔金斯。
Objective: To provide global estimates of the prevalence of injecting drug use (IDU) and HIV prevalence among IDU, in particular to provide estimates for developing and transitional countries.Methods: Collation and review of existing estimates of IDU prevalence and HIV prevalence from published and unpublished documents for the period 1998-2003. The strength of evidence for the information was assessed based on the source and type of study.Results: Estimates of IDU prevalence were available for 130 countries. The number of IDU worldwide was estimated as approximately 13.2 million. Over ten million (78%) live in developing and transitional countries (Eastern Europe and Central Asia, 3.1 million, South and South-east Asia, 3.3 million; East-Asia and Pacific, 2.3 million). Estimates of HIV prevalence were available for 78 countries. HIV prevalence among IDU of over 20% was reported for at least one site in 25 countries and territories: Belarus, Estonia, Kazakhstan, Russia, Ukraine, Italy, Netherlands, Portugal, Serbia and Montenegro, Spain, Libya, India, Indonesia, Malaysia, Myanmar, Nepal, Thailand, Viet Nam, China, Argentina, Brazil, Uruguay, Puerto Rico, USA and Canada.Conclusions: These findings update previous assessments of the number of countries with IDU and HIV-infected IDU, and the previous quantitative global estimates of the prevalence of IDU. However, gaps remain in the information and the strength of the evidence often was weak. (C) 2004 Lippincott Williams Wilkins.